- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cystic Fibrosis Related Diabetes in Japan
Total 500 results
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Japan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusJapan
-
BayerCompletedDiabetic RetinopathyKorea, Republic of, Russian Federation, Hong Kong, Taiwan, United States, Argentina, Japan, Denmark, Israel, Spain, Sweden, China, Colombia, Italy, Portugal
-
Eli Lilly and CompanyAlkermes, Inc.Completed
-
COLM Study Research OrganizationJapan Heart FoundationCompletedHypertension | Cardiovascular Disease | DiabetesJapan
-
Translational Research Center for Medical Innovation...Showa University School of MedicineCompletedDiabetes | Chronic Kidney DiseaseJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novartis PharmaceuticalsCompleted
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential Hypertension | Chronic NephropathyJapan
-
Boehringer IngelheimCompletedDiabetic NephropathiesJapan
-
Aichi Gakuin UniversityUnknownCoronary Artery Disease | Diabetes Mellitus | Impaired Glucose ToleranceJapan
-
Nagoya UniversityUnknownHypertension | Healthy | Diabetes Mellitus | Hyperlipidemia | Metabolic Syndrome XJapan
-
University of the RyukyusCompletedCoronary Artery Disease | Inflammation | Diabetes Mellitus, Type 2 | Diarrhea | Colchicine | White Blood CellJapan
-
Novartis PharmaceuticalsActive, not recruitingProliferative Diabetic RetinopathyChina, India, Japan, Russian Federation, Turkey, Canada, United States, Australia, Korea, Republic of, Brazil, Philippines, Puerto Rico, Taiwan, Argentina, Chile, Mexico
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
Shiga UniversityUnknownHypertension | Diabetes Mellitus | AlbuminuriaJapan
-
Kyorin UniversityCompletedDisease Progression | Autosomal Dominant Polycystic Kidney DiseaseJapan
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Poland, United States, Japan, Korea, Republic of, Germany, Bulgaria, South Africa, Portugal, Ukraine
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
BayerActive, not recruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseJapan, Spain, Netherlands, Denmark, United States
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Korea, Republic of, China, Turkey
-
TakedaCompleted
-
Institute for Clinical Effectiveness, JapanCompletedCoronary Disease | Diabetes Mellitus | Dipeptidyl-Peptidase 4 Inhibitors | LDL Cholesterol | Glycosylated HemoglobinJapan
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Japan, Serbia, China, South Africa, Slovakia
-
BayerCompletedDiabetic Kidney DiseaseBelgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States, India, Italy, Russian Federation, United Kingdom, Canada, Netherlands, Austria, Japan, Spain, Germany, Turkey
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
TakedaCompleted
-
Eli Lilly and CompanyActive, not recruiting
-
GlaxoSmithKlineRecruitingPainUnited States, Germany, Japan, Spain, Canada, China, United Kingdom, South Africa, Korea, Republic of, France, Poland, Turkey
-
AstraZenecaCompletedDiabetes Mellitus Type 2United States, Australia, Canada, Denmark, Finland, Germany, Israel, Italy, Japan, Korea, Republic of, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
PfizerTerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Japan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Taiwan, Korea, Republic of
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
-
Eli Lilly and CompanyCompleted
-
Novo Nordisk A/SCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType2 Diabetes | High Blood SugarJapan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
AstraZenecaCompletedType 2 Diabetes MellitusJapan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
AstraZenecaCompletedType 2 Diabetes MellitusJapan
-
Boehringer IngelheimCompletedDiabetic NephropathiesSpain, Australia, United States, Canada, China, Japan, Malaysia, United Kingdom, Mexico, Portugal, Denmark, Hong Kong, Poland, New Zealand, Argentina, Netherlands